Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Neumora Therapeutics, Inc. (NMRA)

Atara Biotherapeutics, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Neumora Therapeutics, Inc. are of similar size ($92.6M and $90.2M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Atara Biotherapeutics, Inc. leads on 8 and Neumora Therapeutics, Inc. on 4.

Valuation

Metric ATRA NMRA Biotechnology median
P/E n/m n/m 8.68
P/S 22.91 n/m 10.29
P/B n/m 2.00 2.40
Price to free cash flow n/m n/m 20.52
EV/EBITDA n/m n/m 0.68
EV/Sales 21.32 n/m 10.15
Earnings yield (12.50%) (256.25%) (28.86%)
Free cash flow yield (14.82%) (202.88%) (22.44%)

Profitability

Metric ATRA NMRA Biotechnology median
Gross margin 91.38% 0.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (187.11%) (56.66%)
Return on assets (57.62%) (121.89%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA NMRA Biotechnology median
Revenue growth (TTM) (96.72%) — 5.64%
EPS growth (last fiscal year) 122.52% 5.23% 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATRA NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 1.98 4.50 4.72
Net debt to EBITDA (0.22) 0.53 0.96

Dividend

Metric ATRA NMRA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ATRA NMRA Biotechnology median
Market cap 92.64m 90.15m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack